High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$11.4M
$11,410,660
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-03-10 | $250,275 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-03-09 | $500,200 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-03-06 | $737,919x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2026-02-13 | $100,256 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-26 | $503,255x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-20 | $509,225x3 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-12 | $487,231x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-22 | $483,672x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-15 | $483,729x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
|
IRMD
M
IRADIMED CORP
Chiprin Jeff
• Officer • Chief Commercial Officer
Equity Compensation
2025-12-11
$0
|
||||||
| IRMD |
IRADIMED CORP
|
Officer • Chief Commercial Officer
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
CFO
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
CFO
Discretionary Sell
|
2025-12-11 | $1,459,342Largex2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-01 | $463,794x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-24 | $451,814x3 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2025-11-20 | $264,717x6 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-18 | $427,957x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CFO
Discretionary SellΔOwn -81.0%
|
2025-11-10 | $900,162 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-10 | $426,193x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-03 | $413,216x6 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-27 | $388,429x3 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-21 | $374,081x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-13 | $362,964x3 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-06 | $358,614x2 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-01 | $350,957x3 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-09-23 | $356,290 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-09-17 | $356,367x2 | S | Form 4 |